Cite
HARVARD Citation
Markvardsen, L. et al. (n.d.). Subcutaneous immunoglobulin as first‐line therapy in treatment‐naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study. European journal of neurology. pp. 412-418. [Online].